Oxford GlycoSciences (OGS) is an established proteomics-based drug discovery company founded in 1988 by University to identify and analyse glycoproteins. OGS today recognised as a world leader proteomic technology pharmaceutical glycobiology R&D. The success of based on these core technologies support these, has extensive bioinformatics, engineering, automation microfabrication expertise ...